Golexanolone, a GABAA receptor-modulating steroid antagonist, improves neuroinflammation, fatigue, anxiety, depression, and some cognitive and motor alterations in a rat model of Parkinson's diseaseFENS Forum 2024SaveJun 25, 2024Neuroscience